You searched for "information"
Urology around the world: India: past, present, and future
Past India has the largest population in the world, standing at 1.43 billion as of September 2023. This vast population across a huge geographical area brings unique healthcare challenges, including the full range of urologic conditions. Urology is a relatively...Urology around the world: Pioneering paths – my journey as the first and only Italian female urologist in the Muslim world
Maria Colavita. As the first and only Italian female urologist practising in the Muslim world, my journey has been shaped by ambition, grief, cultural curiosity, and ultimately, profound transformation. What began with an unexpected invitation has become a story of...The Parnell Fund Bursary 2019
At the start of July 2019 applications for the Parnell Fund Bursary were opened to trainees, consultants and healthcare professionals across the United Kingdom with an interest in female, functional and neuro-urology. Rachel Barratt, who was awarded the Parnell Fund...Can the latest patient decision aid help OAB patients?
OAB Answers is a patient decision aid co-authored by several European urologists and gynaecologists, and two patient advocates, to help patients understand and manage their overactive bladder (OAB). It is a 36-page document split into several clear sections, aiming to...Meeting in the middle: a review of the rendezvous technique to treat impassable ureteric strictures and transected ureters
Introduction Complex ureteric strictures present a significant challenge with some patients undergoing multiple separate urological and radiological procedures to try to cross a stricture without success. Cross-departmental collaboration with uroradiology may allow a decrease in the number of separate interventions....Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award
Partnership with Academia Award Winner: Femeda Ltd Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from the...Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award
Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from...
The EP2 receptor – a novel target for prostate cancer?
This basic science paper sets out to evaluate the effects that celecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, have on prostate cancer cell lines and evaluated the mechanisms behind these effects. COX-2 induces the production of prostaglandins, which promote cell proliferation...A guide to percutaneous nephrolithotomy
Percutaneous nephrolithotomy (PCNL) is now the gold standard approach to treating large renal stones. Since its development in the 1970s, it has undergone a series of refinements that could only have been possible with the symbiosis of both radiological and...
